Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Trevi Therapeutics, Inc. - Common Stock (NQ:TRVI)

10.53 +0.03 (+0.29%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,497,501
Open 10.48
Bid (Size) 10.53 (38)
Ask (Size) 10.55 (12)
Prev. Close 10.50
Today's Range 10.37 - 10.90
52wk Range 2.360 - 11.11
Shares Outstanding 60,069,512
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Friday's After-Market Session
 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga

Performance

YTD
+141.5%
+141.5%
1 Month
+17.7%
+17.7%
3 Month
+37.8%
+37.8%
6 Month
+59.8%
+59.8%
1 Year
+231.1%
+231.1%

More News

Read More
This Adient Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Via Benzinga
Earnings Scheduled For August 7, 2025
Via Benzinga
Dow Gains Over 100 Points; US Job Openings Increase In April
Via Benzinga
Topics Stocks
Earnings Scheduled For May 8, 2025
Via Benzinga
Earnings Preview For Trevi Therapeutics
Via Benzinga
Trevi Therapeutics Showcases Drug That Cuts Cough Frequency In Lung Disease Patients
Via Benzinga
Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board
From Avalo Therapeutics
Via GlobeNewswire
Earnings Scheduled For March 18, 2025
Via Benzinga
Unusual volume stocks are being observed in Tuesday's session.
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill
Redfin, Mineralys Therapeutics, Trevi Therapeutics And Other Big Stocks Moving Higher On Monday
Via Benzinga
Trevi Therapeutics Reveals Positive Data From Mid-Stage Study For Chronic Cough Candidate, Stock Jumps
Via Benzinga
Top movers in Monday's pre-market session
Via Chartmill
Why Checkpoint Therapeutics Shares Are Trading Higher By Around 66%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Dow Tumbles 200 Points; Liquidity Services Shares Spike Higher
Via Benzinga
Topics Stocks
Gold Falls Sharply; Adobe Shares Dip After Weak Revenue Outlook
Via Benzinga
Nasdaq Down 50 Points; US Initial Jobless Claims Rise
Via Benzinga
Why Is Cough-Focused Trevi Therapeutics Stock Skyrocketing On Thursday?
Via Benzinga
Why Trevi Therapeutics Could Be a Triple-Bagger Biotech Stock
Via MarketBeat
TRVI Stock Earnings: Trevi Therapeutics Misses EPS for Q2 2024
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
TRVI Stock Earnings: Trevi Therapeutics Misses EPS for Q1 2024
Via InvestorPlace

Frequently Asked Questions

Is Trevi Therapeutics, Inc. - Common Stock publicly traded?
Yes, Trevi Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Trevi Therapeutics, Inc. - Common Stock trade on?
Trevi Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Trevi Therapeutics, Inc. - Common Stock?
The ticker symbol for Trevi Therapeutics, Inc. - Common Stock is TRVI on the Nasdaq Stock Market
What is the current price of Trevi Therapeutics, Inc. - Common Stock?
The current price of Trevi Therapeutics, Inc. - Common Stock is 10.53
When was Trevi Therapeutics, Inc. - Common Stock last traded?
The last trade of Trevi Therapeutics, Inc. - Common Stock was at 10/28/25 04:00 PM ET
What is the market capitalization of Trevi Therapeutics, Inc. - Common Stock?
The market capitalization of Trevi Therapeutics, Inc. - Common Stock is 632.53M
How many shares of Trevi Therapeutics, Inc. - Common Stock are outstanding?
Trevi Therapeutics, Inc. - Common Stock has 633M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.